HSBC Emerging Market Sustainable Equity UCITS ETF (HSEM) Cotización

H2 Gas Wasserstoff
Daniel Rheinhardt/IMAGO/NTB
HYDROGEN | POLICY

1 min read

EIB advisor urges “patience” with green hydrogen sector
(Montel) Market participants must be “patient” with Europe’s green hydrogen sector as it will take time to develop, a

Don’t live in denial. If you expect this to touch $2 after UK approval without any major non dilutive cash injection via big pharma partnership or reverse split, it ain't happening. We would be extremely fortunate if it touches .80 to .90 cents. So I wouldn’t be too greedy and get out as soon as pos

Just one more catalyst and boom!   The company has put out a lot of great news , the stock price must be at the bottom , upside potential is absolutely massive 

That would have been a good question except she thought she was better off four years ago. When I think of four years ago, I think of empty shelves at the grocery store and Ivermectin. How have people forgotten Trump's pathetic response to Covid and the millions of people who lost their jobs? Se

Thanks Hoghead - appreciated!

Re-education

[yt]IPRY02KqKJA[/yt]

Werewolves Of London

https://youtu.be/Y4lOlydXPGQ

Get under your skin much...I've been doing this longer than you've been alive.
All of this bs management nonsense, and you are still here.
What does that make you?

Easy there brainiac

Unfortunately, the investor base here, has not demanded this kind of information and transparency. They are largely happy to live on 'forward looking' statements protected under Safe Harbor.

Any scrutiny of the messaging or messenger is met with derision and incredulousness quickly de

Maybe another possibility If Buc. work 16x nac...Promising Role of N-Acetylcysteine in Reducing Airway Mucus in COPD Patients
https://x.com/ThailandMedicaX/status/1851274249392308675
Hopefully Cw, Rio seen his reply in reddit lol etc they get it to good Use instead of up mfs a ss Month

The 'Risk' in the Risk/Reward balance has been taken off the table for my own personal assessment (YMMD) and on the metaphorical floor with todays Anavex Alzheimer trial data revealed at the CTAD, and with a PR.

Agree--I am feeling more optimistic about Blarcamesine for AD than I have

Perhaps you should keep trashing DJT. Wrong as always you are. Spectaculary. So far at least.

Crikey, Elvira is older than I am and that's old!

MDASE?

The Kidney Patient Act ...applies to ALL new oral pho drugs
https://www.congress.gov/bill/118th-congress/house-bill/5074

If included in the dialysis bundle , OLC is less likely to be prescribed ...especially by private dialysis centers ...because of the way the dialysis bundle

Methinks you are in sore need of a new "script writer"........current narrative is tepid and un-CON-vincing!

The straw is so well done!!

The Prospectus!

What's your point? The 1M share buy at .0001 executed at 12:02 PM ET. The tape shows it at 12:18. Always funny business from the Market on things like this. A legitimate company, all other issues aside still seems like unscrupulous behavior on the market side.

And so recent geopolitics is shown how to win through a recent HIRU post! Hiru investors win again!

Could be a dozen reasons. Working like a dog this week. Over 12 hours every day so far 

Sorry I didn't respond sooner, but I was in Central Park, at the annual unveiling of the Trumpkin.

adserv.stocksite.com/images/paulie/trumpkin1.jpg

www.investorshub.com/boards/board.asp?board_id=2581 Paulie's Pixel Palace

I agree with all of this analysis EXCEPT the annoying fact that we now have meaningful competition from a South Korean company that is owned by that gigantic multinational corporation called Merck & Co., Inc.

If we have to file a patent infringement lawsuit against Alteogen, that will

I can tell from your question your a clueless rookie to stock trading. The stupidity and lack of knowledge about this sad clown show of this nonmanagement team tells me your not worthy of notice. Welcome to my world class esteemed ignore list clueless.